[300 Pages Report] Global Bioprocess Integrity Testing systems market demand is anticipated to be valued at US$ 74.2 Million in 2022, forecast to grow at a CAGR of 5.7% to be valued at US$ 136.6 Million from 2022 to 2032. Growth is attributed to increasing the availability of fully automated integrity test systems. From 2016-2021 a CAGR of 5.0% was registered for the biscuit mixes market.
| Report Attribute | Details |
|---|---|
| Projected Growth Rate (2022 to 2032) | 5.7% CAGR |
| Expected Market Value (2022) | US$ 74.2 Million |
| Anticipated Forecast Value (2032) | US$ 136.6 Million |
Many multi-national companies are focusing on new product innovations and are required to follow the GMP guidelines which is the most critical factor in bioprocess Integrity Testing systems These factors contribute to the bioprocess Integrity Testing systems market.
In the manufacturing of sterile drug products, it is critical to access filter Bioprocess Integrity Testing as regulated by regulatory bodies. The filter in the bioprocess is subjected to wear owing to particle load, fluctuations in pressure and temperature, changes in pH, and other factors. The performance of filter elements is crucial in any bioprocess.
Pressure hold testing, bubble point testing, and diffusive flow testing are some of the examples of filter integrity tests. Out of these, the bubble point test is considered simple, economical, and comes with easy applicability.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increasing awareness about the benefits of using the Bioprocess Integrity Testing systems market among healthcare professionals and consumers fuelling the demand for the Bioprocess Integrity Testing systems market. Technological advancements in filter design and manufacturing improve performance, and the increasing availability of fully automated integrity test systems will boost the growth of the market in the forecasting period.
Due to the reliability of the systems, portability, and ease of implementation Bioprocess Integrity Testing is adopted by leading biopharmaceutical players and biotechnology companies. The market for bioprocess Integrity Testing systems would be accelerated due to the accelerated testing capabilities of the systems.
Although the Bioprocess Integrity Testing system market has numerous end-uses, there are numerous obstacles that likely pose a challenge to market growth. Lack of technical expertise and lack of awareness in the developing and underdeveloped economies may impede the growth of the Bioprocess Integrity Testing system market. The High cost associated with testing may also hider the growth of the Bioprocess Integrity Testing system market.
Principal Consultant
North America was the largest market for the Bioprocess Integrity Testing system market and the trend is expected to continue into the forecast period owing to the increasing government support and increasing R&D activities. The technological advancement in the healthcare sector in the region is expected to augment the Bioprocess Integrity Testing system market. The region is forecast to have a 33.0% total share of the Bioprocess Integrity Testing system market.
North America is expected to be the next dominant region witnessing high adoption rates for the Bioprocess Integrity Testing system market during the forecast period due to the increasing demand for biopharmaceuticals and the implementation of drug safety guidelines by the FDA.
According to Future Market Insights Europe accounts for a total 30.0% share in the global Bioprocess Integrity Testing system market. Increasing healthcare investments and the presence of prominent market vendors and providers also benefit Europe’s market.
The global Bioprocess Integrity Testing system market is gaining traction in the region due to increasing research facilities and the developing biopharmaceutical industry and the growth in the biologics market. Also, stringent government guidelines for purity requirements in pharmaceutical and biotechnology manufacturing boost the growth of the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Bugworks Research, Medgenome, BitBio, uFraction, Tasi Group and vertex-scientific-lab-instruments-co-company are some start-up companies operating in the Bioprocess Integrity Testing system market.
Some of the key participants present in the global Bioprocess Integrity Testing system market include Merck Millipore, Eurofins Scientific, Pall Corporation, Sartorius Group, and Viet Anh Scientific Co., Ltd. among others.
Attributed to the presence of such a high number of participants, the market is highly competitive. While global players such as Merck Millipore, Eurofins Scientific, Pall Corporation account for considerable market size, several regional level players are also operating across key growth regions, particularly in the Asia Pacific.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 5.7% from 2022 to 2032 |
| Expected Market Value (2022) | US$ 74.2 Million |
| Anticipated Forecast Value (2032) | US$ 136.6 Million |
| Base Year for Estimation | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in US$ Million and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
FMI projects the global Bioprocess Integrity Testing system market to expand at a 5.7% value CAGR by 2032.
North America is expected to be the most opportunistic with a 33.0% share of the total Bioprocess Integrity Testing system market.
Merck Millipore, Eurofins Scientific, Pall Corporation are some prominent Bioprocess Integrity Testing system market manufacturers.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Bioprocess Integrity Testing Systems Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Bioprocess Integrity Testing Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Product Types
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product Types, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Types, 2022-2032
5.3.1. Destructive Testing
5.3.2. Non-Destructive Testing
5.3.3. Bubble Point Testing
5.3.4. Diffusion Testing
5.3.5. Pressure Hold Testing
5.4. Y-o-Y Growth Trend Analysis By Product Types, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Types, 2022-2032
6. Global Bioprocess Integrity Testing Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Process Types
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Process Types, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Process Types, 2022-2032
6.3.1. Particle-Based
6.3.2. Liquid Property Based
6.4. Y-o-Y Growth Trend Analysis By Process Types, 2017-2021
6.5. Absolute $ Opportunity Analysis By Process Types, 2022-2032
7. Global Bioprocess Integrity Testing Systems Market Analysis 2017-2021 and Forecast 2022-2032, By End Users
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By End Users, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End Users, 2022-2032
7.3.1. Biopharmaceutical Industry
7.3.2. Biotechnology Industry
7.4. Y-o-Y Growth Trend Analysis By End Users, 2017-2021
7.5. Absolute $ Opportunity Analysis By End Users, 2022-2032
8. Global Bioprocess Integrity Testing Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Bioprocess Integrity Testing Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product Types
9.2.3. By Process Types
9.2.4. By End Users
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Types
9.3.3. By Process Types
9.3.4. By End Users
9.4. Key Takeaways
10. Latin America Bioprocess Integrity Testing Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Types
10.2.3. By Process Types
10.2.4. By End Users
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Types
10.3.3. By Process Types
10.3.4. By End Users
10.4. Key Takeaways
11. Europe Bioprocess Integrity Testing Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product Types
11.2.3. By Process Types
11.2.4. By End Users
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Types
11.3.3. By Process Types
11.3.4. By End Users
11.4. Key Takeaways
12. Asia Pacific Bioprocess Integrity Testing Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Malaysia
12.2.1.5. Singapore
12.2.1.6. Australia
12.2.1.7. Rest of Asia Pacific
12.2.2. By Product Types
12.2.3. By Process Types
12.2.4. By End Users
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Types
12.3.3. By Process Types
12.3.4. By End Users
12.4. Key Takeaways
13. MEA Bioprocess Integrity Testing Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Product Types
13.2.3. By Process Types
13.2.4. By End Users
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Types
13.3.3. By Process Types
13.3.4. By End Users
13.4. Key Takeaways
14. Key Countries Bioprocess Integrity Testing Systems Market Analysis
14.1. U.K.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Product Types
14.1.2.2. By Process Types
14.1.2.3. By End Users
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Product Types
14.2.2.2. By Process Types
14.2.2.3. By End Users
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Product Types
14.3.2.2. By Process Types
14.3.2.3. By End Users
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Product Types
14.4.2.2. By Process Types
14.4.2.3. By End Users
14.5. Rest of Latin America
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Product Types
14.5.2.2. By Process Types
14.5.2.3. By End Users
14.6. Germany
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Product Types
14.6.2.2. By Process Types
14.6.2.3. By End Users
14.7. U.K.
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Product Types
14.7.2.2. By Process Types
14.7.2.3. By End Users
14.8. France
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Product Types
14.8.2.2. By Process Types
14.8.2.3. By End Users
14.9. Spain
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Product Types
14.9.2.2. By Process Types
14.9.2.3. By End Users
14.10. Italy
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Product Types
14.10.2.2. By Process Types
14.10.2.3. By End Users
14.11. Rest of Europe
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Product Types
14.11.2.2. By Process Types
14.11.2.3. By End Users
14.12. China
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Product Types
14.12.2.2. By Process Types
14.12.2.3. By End Users
14.13. Japan
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Product Types
14.13.2.2. By Process Types
14.13.2.3. By End Users
14.14. South Korea
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Product Types
14.14.2.2. By Process Types
14.14.2.3. By End Users
14.15. Malaysia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Product Types
14.15.2.2. By Process Types
14.15.2.3. By End Users
14.16. Singapore
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Product Types
14.16.2.2. By Process Types
14.16.2.3. By End Users
14.17. Australia
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Product Types
14.17.2.2. By Process Types
14.17.2.3. By End Users
14.18. Rest of Asia Pacific
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Product Types
14.18.2.2. By Process Types
14.18.2.3. By End Users
14.19. GCC Countries
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Product Types
14.19.2.2. By Process Types
14.19.2.3. By End Users
14.20. South Africa
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2021
14.20.2.1. By Product Types
14.20.2.2. By Process Types
14.20.2.3. By End Users
14.21. Israel
14.21.1. Pricing Analysis
14.21.2. Market Share Analysis, 2021
14.21.2.1. By Product Types
14.21.2.2. By Process Types
14.21.2.3. By End Users
14.22. Rest of MEA
14.22.1. Pricing Analysis
14.22.2. Market Share Analysis, 2021
14.22.2.1. By Product Types
14.22.2.2. By Process Types
14.22.2.3. By End Users
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product Types
15.3.3. By Process Types
15.3.4. By End Users
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Merck Millipore
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Eurofins Scientific
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Pall Corporation
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Sartorius Group
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Viet Anh Scientific Co., Ltd.
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Healthcare
January 2023
REP-GB-13912
309 pages
Explore Healthcare Insights
View Reports
Bioprocess Integrity Testing Systems Market
